Incidence and risk factors for myelofibrotic transformation among 272 Chinese patients with JAK2-mutated polycythemia vera-Reference-Cited by-同舟云学术

Incidence and risk factors for myelofibrotic transformation among 272 Chinese patients with JAK2-mutated polycythemia vera

Published:2015-11-17 Issue:12 Volume:90 Page:1116-1121
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Bai Jie¹,Ai Limei²,Zhang Lei¹,Yang Feng-Chun³,Zhou Yuan¹,Xue Yanping¹

Affiliation:

1. State Key Laboratory of Experimental Hematology; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Tianjin People's Republic of China

2. Department of Hematology; The First Affiliated Hospital of Liaoning Medical University; Jinzhou People's Republic of China

3. Department of Biochemistry and Molecular Biology; Sylvester Comprehensive Cancer Center, University of Miami Leonard M. Miller School of Medicine; Miami Florida

Funder

National Natural Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Hematology

Reference30 articles.

1. Acute leukemia in polycythemia vera: An analysis of 1638 patients enrolled in a prospective observational study;Finazzi;Blood,2005

2. A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis;Passamonti;Blood,2008

3. Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study;Tefferi;Leukemia,2013